These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9260741)

  • 1. In vivo protection of striatal dopaminergic system against 1-methyl-4-phenylpyridinium neurotoxicity by phenobarbital.
    Vizuete ML; Merino M; Cano J; Machado A
    J Neurosci Res; 1997 Aug; 49(3):301-8. PubMed ID: 9260741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of involvement of glutamate-induced excitotoxicity in MPP+ toxicity in striatal dopaminergic terminals: possible involvement of ascorbate.
    Matarredona ER; Santiago M; Machado A; Cano J
    Br J Pharmacol; 1997 Jul; 121(5):1038-44. PubMed ID: 9222565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Less induced 1-methyl-4-phenylpyridinium ion neurotoxicity on striatal slices from guinea-pigs fed with a vitamin C-deficient diet.
    Revuelta M; Romero-Ramos M; Venero JL; Millan F; Machado A; Cano J
    Neuroscience; 1997 Mar; 77(1):167-74. PubMed ID: 9044384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain inflammation enhances 1-methyl-4-phenylpyridinium-evoked neurotoxicity in rats.
    Goralski KB; Renton KW
    Toxicol Appl Pharmacol; 2004 May; 196(3):381-9. PubMed ID: 15094308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats.
    Espino A; Cutillas B; Tortosa A; Ferrer I; Bartrons R; Ambrosio S
    Brain Res; 1995 Oct; 695(2):151-7. PubMed ID: 8556325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
    Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of carboxyfullerene on MPP+/MPTP-induced neurotoxicity.
    Lin AM; Yang CH; Ueng YF; Luh TY; Liu TY; Lay YP; Ho LT
    Neurochem Int; 2004 Jan; 44(2):99-105. PubMed ID: 12971912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the neuroprotective effect of dehydroepiandrosterone and 17beta-estradiol against 1-methyl-4-phenylpyridium toxicity on rat striatum.
    Tomas-Camardiel M; Sanchez-Hidalgo MC; Sanchez del Pino MJ; Navarro A; Machado A; Cano J
    Neuroscience; 2002; 109(3):569-84. PubMed ID: 11823067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased extracellular glutamate evoked by 1-methyl-4-phenylpyridinium [MPP(+)] in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione.
    Foster SB; Tang H; Miller KE; Dryhurst G
    Neurotox Res; 2005; 7(4):251-63. PubMed ID: 16179262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of the iron chelator desferrioxamine against MPP+ toxicity on striatal dopaminergic terminals.
    Santiago M; Matarredona ER; Granero L; Cano J; Machado A
    J Neurochem; 1997 Feb; 68(2):732-8. PubMed ID: 9003064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
    Moy LY; Albers DS; Sonsalla PK
    Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+.
    Merino M; Vizuete ML; Cano J; Machado A
    J Neurochem; 1999 Aug; 73(2):750-7. PubMed ID: 10428073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
    Wu WR; Zhu ZT; Zhu XZ
    Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
    Park TH; Mytilineou C
    Brain Res; 1992 Dec; 599(1):83-97. PubMed ID: 1362921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral Administration of Tetanus Toxin Hc Fragment Prevents MPP
    Moreno-Galarza N; Mendieta L; Palafox-Sánchez V; Herrando-Grabulosa M; Gil C; Limón DI; Aguilera J
    Neurotox Res; 2018 Jul; 34(1):47-61. PubMed ID: 29460114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen as a neuromodulator of MPTP-induced neurotoxicity: effects upon striatal dopamine release.
    Disshon KA; Dluzen DE
    Brain Res; 1997 Aug; 764(1-2):9-16. PubMed ID: 9295188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effect of apomorphine and haloperidol on MPP neurotoxicity.
    Espinosa-Oliva AM; de Pablos RM; Santiago M
    Pharmacology; 2014; 93(3-4):101-7. PubMed ID: 24556705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetaminophen and aspirin inhibit superoxide anion generation and lipid peroxidation, and protect against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats.
    Maharaj DS; Saravanan KS; Maharaj H; Mohanakumar KP; Daya S
    Neurochem Int; 2004 Apr; 44(5):355-60. PubMed ID: 14643753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection and potentiation of 1-methyl-4-phenylpyridinium-induced toxicity by cytochrome P450 inhibitors and inducer may be due to the altered uptake of the toxin.
    Sriram K; Pai KS; Ravindranath V
    J Neurochem; 1995 Mar; 64(3):1203-8. PubMed ID: 7861152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.